454 related articles for article (PubMed ID: 19594841)
1. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
Miller D; Richardson D; Eisa M; Bajwa RJ; Jabbari B
Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
3. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial.
Singh JA; Mahowald ML; Noorbaloochi S
Transl Res; 2009 May; 153(5):205-16. PubMed ID: 19375681
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
6. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
Braker C; Yariv S; Adler R; Badarny S; Eisenberg E
Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
Carroll A; Barnes M; Comiskey C
Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study.
Boon AJ; Smith J; Dahm DL; Sorenson EJ; Larson DR; Fitz-Gibbon PD; Dykstra DD; Singh JA
PM R; 2010 Apr; 2(4):268-76. PubMed ID: 20430328
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
Lew HL; Lee EH; Castaneda A; Klima R; Date E
Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
[TBL] [Abstract][Full Text] [Related]
10. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study.
Freund BJ; Schwartz M
J Rheumatol; 2000 Feb; 27(2):481-4. PubMed ID: 10685817
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
Kuo HC; Chancellor MB
BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
[TBL] [Abstract][Full Text] [Related]
13. Low back ache treatment with botulinum neurotoxin type A. Local experience in Kuwait.
Nagarajan V; Al-Shubaili A; Ayad YM; Alexander J; Al-Ramezi K
Med Princ Pract; 2007; 16(3):181-6. PubMed ID: 17409751
[TBL] [Abstract][Full Text] [Related]
14. Treatment of refractory, chronic low back pain with botulinum neurotoxin A: an open-label, pilot study.
Jabbari B; Ney J; Sichani A; Monacci W; Foster L; Difazio M
Pain Med; 2006; 7(3):260-4. PubMed ID: 16712627
[TBL] [Abstract][Full Text] [Related]
15. Duration of migraine is a predictor for response to botulinum toxin type A.
Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
[TBL] [Abstract][Full Text] [Related]
16. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
Tobinick E; Davoodifar S
Curr Med Res Opin; 2004 Jul; 20(7):1075-85. PubMed ID: 15265252
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
Schulte-Mattler WJ; Krack P;
Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132
[TBL] [Abstract][Full Text] [Related]
19. Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases.
Tepper SJ; Bigal ME; Sheftell FD; Rapoport AM
Headache; 2004 Sep; 44(8):794-800. PubMed ID: 15330826
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
Kong KH; Neo JJ; Chua KS
Clin Rehabil; 2007 Jan; 21(1):28-35. PubMed ID: 17213238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
